FEROZA THOMPSON: Open Payments
NPI 1891940698 · MESQUITE, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 40 payments from 12 companies in 2025. Trend: 2023 $642 · 2024 $973 · 2025 $1,891
Food & beverage: $1,822Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $475 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $324 |
| Janssen Biotech, Inc. | 5 | $200 |
| Incyte Corporation | 2 | $186 |
| UCB, Inc. | 4 | $163 |
| Amgen Inc. | 4 | $163 |
| GENZYME CORPORATION | 1 | $119 |
| Novartis Pharmaceuticals Corporation | 2 | $89 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Organon LLC | 3 | $38 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Opzelura, Bimzelx, Winlevi, RINVOQ, Leqselvi.
Industry payments across NV — which companies pay providers there.
